In Follow-up

AspECT

A phase III, randomised study of aspirin and esomeprazole chemoprevention in Barrett’s metaplasia.
(click here for details)

COG

Randomised phase III trial of gefitinib 500 mg once daily versus placebo in oesophageal cancer progressing after chemotherapy.
(click here for details)

QUASAR 2

Multicentre international study of capecitabine ± bevacizumab as adjuvant treatment of colorectal cancer.
(click here for details)